FDA releases Clolar data

There were no surprises in data released by FDA and Ilex about ILXO's Clolar clofarabine in advance of Wednesday's Oncologic Drugs Advisory Committee meeting. ODAC's discussion of Clolar is

Read the full 292 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE